Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
Monday, June 13, 2011 - 12:30
in Health & Medicine
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
